stereotactic body radiotherapy (SBRT)

May 13, 2019

Evidence Supports Stereotactic Body Radiotherapy as a Standard of Care for Localized PC

News

Cumulative evidence to date supports the implementation of stereotactic body radiotherapy — a highly precise radiation therapy delivered in shorter periods of time — as a standard treatment for people ... Read more

March 18, 2019

Some PC Patients Can Safely Receive Short but Intense Course of Radiation

News

Stereotactic body radiotherapy (SBRT), which delivers higher doses of radiation over a significantly shorter period of time, can be safely given to men with low- or intermediate-risk prostate cancer with similar ... Read more

November 1, 2018

Certain Prostate Cancer Patients May Benefit From Higher Radiation Doses in Fewer Sessions, Study Shows

News

Stereotactic body radiation therapy (SBRT) — a kind of radiation therapy that delivers high doses of radiation over a shorter treatment course — is as safe and effective as the ... Read more

October 26, 2018

Stereotactic Radiation Shows Ability to Significantly Extend Survival in Cancer Patients with Multiple Metastasis

News

Patients whose cancer returns at multiple sites after treatment — called oligometastatic cancer — are generally thought incurable, but a recent Phase 2 trial found that a highly precise form ... Read more

October 19, 2017October 19, 2017

SpaceOAR Protects Surrounding Prostate Tissues from Radiation Therapy, Phase 2 Trial Shows

News

Augmenix’s SpaceOAR System can effectively protect the rectum of prostate cancer patients undergoing high dose stereotactic body radiation therapy (SBRT), a new prospective Phase 2 trial shows. The findings were recently reported ... Read more

September 28, 2017September 28, 2017

Accuray: 93% of Low-risk Prostate Cancer Patients Disease-free 10 Years After CyberKnife Therapy

News

More than 93 percent of men with low risk-prostate cancer treated with the CyberKnife System were still disease-free 10 years later, said the system’s manufacturer, Sunnyvale, California-based Accuray. A study detailing the treatment, “Stereotactic Body Radiotherapy ... Read more

September 29, 2016September 29, 2016

Precision Radiotherapy, SBRT, Shows Promise as 1st Treatment for Low- and Medium-Risk Prostate Cancers

News

Men newly diagnosed with low- or intermediate-risk prostate cancer may benefit more by being treated with high-dose stereotactic body radiotherapy (SBRT) as a first therapy than with other available radiotherapies, according to ... Read more